A STUDY ON THE MANUFACTURE AND INVITRO DISSOLUTION OF TERBUTALINE SULFATE MICROCAPSULES AND THEIR TABLETS

被引:22
作者
RUIZ, R [1 ]
SAKR, A [1 ]
SPROCKEL, OL [1 ]
机构
[1] UNIV CINCINNATI,COLL PHARM,DIV PHARMACEUT & DRUG DELIVERY SYST,CINCINNATI,OH 45267
关键词
D O I
10.3109/03639049009025790
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microcapsules of terbutaline sulfate with cellulose acetate butyrate and ethylcellulose were prepared using an emulsion-solvent evaporation technique. The in vitro dissolution of terbutaline sulfate was studied using the USP rotating basket method. As the polymer to drug ratio increased, the microcapsule size distribution shifted to the smaller size and the release of terbutaline sulfate decreased. The release of terbutaline sulfate was independent of the dissolution medium pH for both polymers. The release kinetics from the microcapsules was dependent on the polymer type and polymer to drug ratio. The release of terbutaline sulfate from cellulose acetate butyrate and ethylcellulose microcapsules formulated with a 1:1 polymer to drug ratio was complex and could not be differentiated between the square-root of time and first-order release models. However, the square-root of time model was followed by microcapsules formulated with a 2:1 or a 3:1 cellulose acetate butyrate to drug ratio. When the ethylcellulose to drug ratio was increased to 2:1 the square-root of time model was followed. At an ethylcellulose to drug ratio of 3:1 the release kinetics could not be differentiated between the Hixon-Crowell and first-order release models. The T50% from ethylcellulose microcapsules was decreased when the microcapsules were compressed into tablets with the addition of AvicelR/EmcompressR (2:1) or AvicelR. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:1829 / 1842
页数:14
相关论文
共 16 条
[1]   THE PROLONGATION OF THE INVITRO DISSOLUTION OF A SOLUBLE DRUG (PHENETHICILLIN POTASSIUM) BY MICROENCAPSULATION WITH ETHYL CELLULOSE [J].
ALPAR, HO ;
WALTERS, V .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (07) :419-422
[2]  
ANDERSSON KE, 1984, EUR J RESPIR DIS, V65, P165
[3]  
GOTO S, 1985, J PHARMACOBIO-DYNAM, V8, P270
[4]  
Goto S, 1984, J Microencapsul, V1, P137, DOI 10.3109/02652048409038518
[5]  
ITOH M, 1980, CHEM PHARM BULL, V28, P1051
[6]   INVITRO DISSOLUTION OF PHENOBARBITONE SODIUM FROM ETHYL CELLULOSE MICROCAPSULES [J].
JALSENJAK, I ;
NICOLAIDOU, CF ;
NIXON, JR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (12) :912-914
[7]  
KAWASHIMA Y, 1984, DRUG DEV IND PHARM, V10, P467, DOI 10.3109/03639048409041400
[8]  
KAWATA M, 1986, CHEM PHARM BULL, V34, P2618
[9]   RECENT ADVANCES IN MICROENCAPSULATION TECHNOLOGY AND EQUIPMENT [J].
LI, SP ;
KOWARSKI, CR ;
FELD, KM ;
GRIM, WM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (2-3) :353-376
[10]  
MORTADA SM, 1982, PHARMAZIE, V37, P427